Link to this page
Medical Subject Headings
Last uploaded:
January 16, 2025
Jump to:
Id | http://purl.bioontology.org/ontology/MESH/D010431
http://purl.bioontology.org/ontology/MESH/D010431
|
---|---|
Preferred Name | Pentoxifylline |
Definitions |
A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production.
|
Synonyms |
BL191
Agapurin
BL-191
1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-
Trental
Oxpentifylline
BL 191
Torental
Pentoxil
|
Type | http://www.w3.org/2002/07/owl#Class |
All Properties
definition | A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production. |
---|---|
altLabel |
BL191
Agapurin
BL-191
1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-
Trental
Oxpentifylline
BL 191
Torental
Pentoxil
See more
See less
|
prefLabel | Pentoxifylline
|
TH |
USAN (1976)
NLM (1990)
FDA SRS (2014)
UNK (19XX)
INN (19XX)
NLM (2010)
USP (19XX)
BAN (19XX)
See more
See less
|
notation | D010431
|
RR | 6493-05-6 (Pentoxifylline)
|
DX | 19910101
|
Machine permutation | 91; see THEOBROMINE 1977-90
|
MN | D03.633.100.759.758.824.651.700
|
PA |
D010975
D011837
D016166
D010726
D014665
|
MMR | 20160531
|
Mapped from |
See more
See less
|
AQL | AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
HN | 91(77)
|
subClassOf | |
Semantic type UMLS property | |
Inverse of RB |
SD6QCT3TSU
0
|
LT | TRD
|
DC | 1
|
MDA | 19760416
|
type | |
tui |
T109
T121
|
cui |
C0729163
C0699487
C0699489
C0699488
C1256382
C0030899
See more
See less
|
isa | |
Inverse of AQ |
See more
See less
|
TERMUI |
T030825
T030822
T030820
T030824
T030823
T030821
T748995
See more
See less
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |